Rising Number of Drug Development Programs Boost ADME Toxicology Testing Market

A new market intelligence study by Transparency Market Research presents a detailed overview of the global ADME toxicology testing market. The report is titled “ADME Toxicology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.” The market research study provides a comprehensive analysis of the growth drivers, factors limiting growth, current trends, and projections of the market for the period from 2013 to 2019.

ADME is the abbreviation for absorption distribution, metabolism and elimination. It is a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. The aforementioned four processes influence the performance of a drug on human tissue. ADME toxicology testing is used for the development of a new drug. The growing use of ADME toxicology testing by pharmaceuticals and biotechnology companies is boosting the ADME toxicology testing market. ADME toxicology testing is increasingly adopted by pharma companies to reduce their drug testing, drug development, and drug discovery costs.

The rising number of drug developments is one of the major drivers of the ADME toxicology testing market. A reduced number of drug failures owing to the adoption of ADME toxicology testing is fueling the demand from pharmaceutical and biotechnology companies. Technological advancements such as the use of in-silico techniques that make use of computer-based testing methods to get fast results are expected to drive the ADME toxicology testing market in the future. Similarly, modern cell-based assays will aid the market’s growth.

On the basis of geography, the global ADME toxicology testing market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Asia Pacific is expected to be the fastest growing market in the coming years as the region is expected to receive support from several governments. Collaborations of companies based in APAC with foreign research and pharmaceutical companies will also help drive the market in the region. North America holds the largest share in the global ADME toxicology testing market and is expected to retain its dominant position for the rest of the forecast period. Europe is the second largest market in the global ADME toxicology testing market.

Request free Sample pages of premium Research Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1778

The report profiles the leading players of the global ADME toxicology testing market, for the purpose of the study. The detailed overview of each of the companies has been included in the report, comprising a business overview, financial overview, market strategies, recent developments, and much more. Key players profiled in the report are: Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Caliper Life Sciences, Inc., Beckman Coulter, Inc., Cyprotex PLC., Life Technologies Corporation, Cellartis AB, Molecular Discovery Ltd., Optivia Biotechnology, Inc., and Accelrys, Inc.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.